SCHEMBL6203110

SCHEMBL6203110

ClCCc1cnc(Cl)nc1Cl

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.31
CSNK1A1 P48729 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31
PDXK O00764 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203090 0.81 KDM4E (0.31) KDM4E
SCHEMBL6219173 0.81 AURKA (0.34) KDM4E
SCHEMBL6204668 0.81 PDXK (0.37) KDM4EPDXK
SCHEMBL6206164 0.78 PDXK (0.35) PDXK
SCHEMBL30135451 0.76 JUN (0.33)
SCHEMBL791580 0.76 KCNH2 (0.36) KDM4E
SCHEMBL7966254 0.76 KDM4E (0.32) KDM4ECSNK1A1CLK4PDXK
SCHEMBL4579208 0.76 NOS3 (0.36) KDM4ECSNK1A1CLK4PDXK
SCHEMBL30238970 0.76 NOS3 (0.36) KDM4ECSNK1A1CLK4PDXK
SCHEMBL15942981 0.76 ALDH1A1 (0.33) KDM4ECSNK1A1CLK4PDXK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560829-A1 PYRIMIDO COMPOUNDS HAVING ANTIPROLIFERATIVE ACTIVITY (II) F. HOFFMANN-LA ROCHE AG (CH) 2005-08-10 EP disclosed
EP-1560832-A1 PYRIMIDO 4,5-D PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2005-08-10 EP disclosed
WO-2004041822-A1 PYRIMIDO[4,5-D]PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2004-05-21 WO disclosed
WO-2004041821-A1 PYRIMIDO COMPOUNDS HAVING ANTIPROLIFERATIVE ACTIVITY (II) F. HOFFMANN-LA ROCHE AG (CH) 2004-05-21 WO disclosed
WO-2003009852-A1 TYROSINE KINASE INHIBITORS MERCK & CO., INC. (US) 2003-02-06 WO disclosed